Méhnyakrák: vizsgálatok itt: Kanada
14 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Hamilton, London, Montreal, Ste-Foy, Toronto
- Életkor
- 15 év and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - 3. fázisTaking peopleA Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Where
- Calgary, Edmonton, Halifax, London, Montreal, Québec, Sherbrooke, Toronto
- Életkor
- 18 év and over
- People
- 1023 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Halifax, Montreal, Toronto
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 2. fázisNot yet taking people in KanadaAdaptive Radiotherapy for Safe Hypofractionation
- Where
- Montreal
- People
- 264
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT07516210 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Edmonton, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 2. fázisTaking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Edmonton, Montreal
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Edmonton, Hamilton, Montreal, Ottawa, Toronto, Vancouver
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1/2. fázisTaking peopleA Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 366 worldwide
- Run by
- Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01 - No phaseTaking peopleA Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Where
- Montreal, Toronto
- Életkor
- 18 év and over
- People
- 840 worldwide
- Run by
- GOG Foundation
See details and how to joinNCT04831580 - No phaseTaking peopleFDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 64
- Run by
- University Health Network, Toronto
See details and how to joinNCT03853915 - 1/2. fázisTaking peopleA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Where
- Toronto
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT05941507 - 2. fázisTaking peopleFIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- Where
- Québec, Toronto
- Életkor
- 18 év to 40 év
- People
- 31 worldwide
- Run by
- University Health Network, Toronto
See details and how to joinNCT04016389 · EU 2023-507230-24-00 - No phaseTaking peopleScreening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
- Where
- Toronto
- Életkor
- 40 év and over
- People
- 110
- Run by
- Dr. Danielle Vicus
See details and how to joinNCT03061435 - 2. fázisTaking peopleHypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study
- Where
- Kelowna, London, Toronto
- Életkor
- 18 év and over
- People
- 48
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT04583254